Systemic anti-cancer therapies, including chemotherapy, targeted therapies, immunotherapies, and hormone treatments, are essential components of modern oncology. In patients with metastatic disease, ...

Loss of GATA6-a transcription factor that controls which genes are turned on or off-can reprogram colorectal cancer cells ...

Researchers say approach could be useful for both initial treatment of bladder cancer as well as treatment refractory subsets of tumors.

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...

Researchers at Mayo Clinic have uncovered a previously hidden step in how the immune system prepares to fight cancer, a ...

Glioblastoma (GBM) is the most common primary brain cancer with over 12,000 new cases per year in the US 1. Patients with GBM usually decline rapidly, with a 5-year survival rate of just 5% and a ...

Researchers found that loss of GATA6 reprograms colorectal cancer cells into flexible, fetal-like states that can spread to ...

Loss of GATA6—a transcription factor that controls which genes are turned on or off—can reprogram colorectal cancer cells ...

Cancer cells that disseminate from a tumor can enter a period of dormancy that may persist from months to decades before metastasis. Efforts to improve adjuvant therapy to remove residual cancer cells ...

UCT-led researchers decoded how cancer rewires the MUC1 protein’s sugar coating to evade immune detection, paving the way for ...

Michigan State University researchers have identified how ovarian cancer cells become resistant to chemotherapy and ...

Therapeutic cancer vaccines often fail to generate strong enough immune responses, in part because traditional “blender-style” formulations ignore how the structural arrangement of components ...